title: Myotoxic phospholipases A(2) in bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu.
abstract: Venoms from eight Bothrops spp. were fractionated by ion-exchange chromatography on CM-Sepharose at pH 8.0 for the purification of myotoxins. Chromatographic profiles showed differences regarding myotoxic components among these venoms. B. alternatus, B. atrox and B. jararaca venoms did not show the major basic myotoxic fractions identified in the other venoms. Polyacrylamide gel electrophoresis for basic proteins also showed distinct patterns for these toxins. In vivo, all the isolated myotoxins induced release of creatine kinase due to necrosis of muscle fibers, accompanied by polymorphonuclear cell infiltration, and edema in the mouse paw. In addition, the toxins showed cytotoxic and liposome-disrupting activities in vitro. B. jararacussu bothropstoxins-I (BthTX-I) and II (BthTX-II) were submitted to chemical modifications of: His, by 4-bromophenacyl bromide (BPB) or photooxidation by Rose Bengal (RB); Tyr, by 2-nitrobenzenesulphonyl fluoride (NBSF); and Trp, by o-nitrophenylsulphenyl chloride (NPSC). The myotoxic and cytotoxic activities of BthTX-I, a Lys49 PLA(2) homologue, after modification by BPB, RB, NBSF and NPSC, were reduced to 50%, 20%, 75%, 65% and 13%, 0.5%, 76%, 58%, respectively. However, the edema-inducing and liposome-disrupting activities were not significantly reduced by the above modifications. BPB-treated BthTX-II, an Asp49 PLA(2) homologue, lost most of its catalytic, indirect hemolytic, anticoagulant, myotoxic and cytotoxic activities. The edema-inducing and liposome-disrupting activities were reduced to 50% and 80%, respectively. Lethality caused by BthTX-I and -II was strongly reduced after treatment with BPB or RB, but only partially with NBSF or NPSC. BthTX-I and -II, both native or modified, migrated similarly in a charge-shift electrophoresis. Antibodies raised against BthTX-I or -II, B. asper Basp-II and the C-terminal 115-129 peptide from Basp-II did not show significant differences in their cross-reactivity with the modified toxins, except with RB photooxidized toxins.
authors.affiliation: Departamento de Bioquímica, Faculdade de Medicina, Universidade de São Paulo, 14049-900, SP, Ribeirão Preto, Brazil.
authors.forename: S H
authors.initials: SH
authors.lastname: Andrião-Escarso
authors.forename: A M
authors.initials: AM
authors.lastname: Soares
authors.forename: V M
authors.initials: VM
authors.lastname: Rodrigues
authors.forename: Y
authors.initials: Y
authors.lastname: Angulo
authors.forename: C
authors.initials: C
authors.lastname: Díaz
authors.forename: B
authors.initials: B
authors.lastname: Lomonte
authors.forename: J M
authors.initials: JM
authors.lastname: Gutiérrez
authors.forename: J R
authors.initials: JR
authors.lastname: Giglio
mesh_terms: D000818:Animals; D017837:Bothrops; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002852:Chromatography, Ion Exchange; D003435:Crotalid Venoms / Q000737:chemistry / Q000302:isolation & purification / Q000633:toxicity*; D004487:Edema / Q000139:chemically induced; D007928:Lethal Dose 50; D008081:Liposomes; D008297:Male; D051379:Mice; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000473:pathology; D009336:Necrosis; D010741:Phospholipases A / Q000302:isolation & purification / Q000633:toxicity*
chemical_list: D003435:Crotalid Venoms; D008081:Liposomes; C078097:bothropstoxin; D010741:Phospholipases A